News
Clinical Trials Arena on MSN17h
Pfizer reports positive results from Phase III BAISIS trial for haemophiliaPfizer has reported positive topline outcomes from the multicentre, open-label Phase III BASIS trial of Hympavzi (marstacimab ...
Topline data were announced from a phase 3 trial evaluating marstacimab for adults and adolescents living with hemophilia A or B with inhibitors.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback